Although we have explored pilot UBE20 expression using human TMA prostate cancer tissue, UBE2O/antibody used validated antibody from Sigma-Aldrich but could not detect UBE2O expression in any of the 494 prostate cancer tissues. Here, UBE2O is linked to prostate carcinoma.